AB-1005 Long-Term Follow-up Study

NCT07081841 · tracked via the Priya Life Science USA tracker

Sponsor

AskBio Inc

Phase

Observational

Started

2025-09-04

Last updated

2025-10-02

Condition(s) studied

Parkinson's DiseaseMultiple System Atrophy, Parkinson Variant

Investigational drug(s) / intervention(s)

Observation

Observation: This is an observational study in which safety laboratories and non-invasive routine clinical assessments are conducted to gauge long term safety and efficacy.

Study summary

This is an observational, long term, follow-up study for participants with Parkinson's disease (PD) or Multiple System Atrophy-Parkinsonian subtype (MSA-P) who participated in prior interventional studies with AB-1005. It is intended to better understand the long-term safety of AB-1005, how well tolerated it is and how long lasting the effects are.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * PD and MSA-P participants that are or were enrolled in an interventional AB-1005 study and provide informed consent Exclusion Criteria: * There are no exclusion criteria

Primary outcome measure(s)

Long term safety and tolerability — Up to 10 years post surgery
Measure of the occurrence of serious and non-serious adverse events

Trial sites (2)

Facility	City	Region	Status
University of California San Francisco	San Francisco	California
Ohio State University	Columbus	Ohio

More AskBio Inc trials in the USA

A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD) Recruiting

A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) Recruiting

Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure Active, not recruiting

Prescriptive Infusion Algorithm (PIA) Starting soon

A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1) Active, not recruiting

Other trials for the same condition

A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations Recruiting

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease Recruiting

A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease Active, not recruiting

A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease Active, not recruiting

GDNF Gene Therapy for Parkinson's Disease Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07081841 on ClinicalTrials.gov ↗ ← All trials in the USA